Your browser doesn't support javascript.
loading
Effect Of Risperidone And Clozapine On Executive Functions In First Episode Schizophrenia
Article | IMSEAR | ID: sea-185463
ABSTRACT

Aims:

To compare the effect of risperidone and cloazpine on executive functioning in treatment naïve first episode schizophrenia.

Methods:

A total of 55 treatment naïve first episode patients of schizophrenia as per ICD-10 criteria, were enrolled for the study. Baseline assessment for executive functioning was carried out with TMT- A& B. Clozapine and risperidone were used in the range of 200-600mg/ day and 4- 8 mg/day respectively for 6 months.

Results:

There was significant improvement in executive functioning in both the groups and the results were statistically significant for clozapine on TMT-B.

Conclusion:

The findings of current study show that both risperidone and clozapine lead to improvement in executive functioning in first episode of schizophrenia and clozapine fared better than risperidone.

Texte intégral: Disponible Indice: IMSEAR (Asie du Sud-Est) Type d'étude: Étude pronostique Année: 2018 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: IMSEAR (Asie du Sud-Est) Type d'étude: Étude pronostique Année: 2018 Type: Article